Search Within

Sujata Patil

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (28)
Groups
  1. Biostatistics Service (58)
  2. Epidemiology and Biostatistics (58)
  3. Human Oncology and Pathogenesis Program (58)
  4. Department of Medicine (56)
  5. Solid Tumor Oncology Division (56)
  6. GSK Faculty (50)

More Groups

People
  1. Sarat Chandarlapaty (28)
  2. Clifford Hudis (27)
  3. Shanu Modi (24)
  4. Martin Voss (19)
  5. Robert Motzer (19)
  6. Abraham Hakimi (18)

More People

Years
  1. 2022 (2)
  2. 2021 (6)
  3. 2020 (3)
  4. 2019 (7)
  5. 2018 (2)
  6. 2017 (4)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Cancer Research (11)
  3. Clinical Cancer Research (7)
  4. Clinical Breast Cancer (3)
  5. Clinical Genitourinary Cancer (3)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. American Society of Clinical Oncology (17)
  3. Elsevier Inc. (6)
  4. Nature Publishing Group (3)
  5. Oxford University Press (3)
  6. Springer (3)

More Publishers

Results (58)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Monitoring PIK3CA mutant allele fraction (AF) in cell-free DNA (cfDNA) in metastatic breast cancer (MBC) patients treated with PI3K alpha-inhibitor plus letrozole (L) or exemestane (E)
    Meeting Abstract

    Moynahan, M. E.; Sung, P.; Asham, M.; Zamora, S.; Shah, P. D.; Modi, S.; Lake, D.; D'Andrea, G.; Goldfarb, S. B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors
    Journal Article

    Feldman, D. R.; Iyer, G.; Van Alstine, L.; Patil, S.; Al-Ahmadie, H.; Reuter, V. E.; Bosl, G. J.; Chaganti, R. S.; Solit, D. B.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies
    Journal Article

    Voss, M. H.; Bastos, D. A.; Karlo, C. A.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Hsieh, J. J.; Molina, A. M.; Patil, S.; Motzer, R. J.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Treatment outcome with mTOR inhibitors for 65 cases of non-clear cell renal cell carcinoma: Association of long-term responses and oncogenomic events
    Meeting Abstract

    Voss, M. H.; Bastos, D. A.; Karlo, C.; Patil, S.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Molina, A. M.; Berger, M. F.; Hsieh, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effect of margin width on local recurrence (LR) in triple-negative (TN) breast cancer treated with breast-conserving therapy (BCT)
    Meeting Abstract

    Pilewskie, M. L.; Ho, A. Y.; Orell, E.; Stempel, M.; Chen, Y.; Eaton, A.; Patil, S.; Morrow, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors (HSP90i)
    Meeting Abstract

    Jhaveri, K. L.; Iyengar, N. M.; Corben, A.; Patil, S.; Akram, M.; Towers, R.; Sakr, R.; Hudis, C.; King, T. A.; Rosen, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save